Sr. Director, Clinical Pharmacology and Clinical Development
Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc.
Disclosure(s): Innoviva Specialty Therapeutics, Inc: employee, Stocks/Bonds (Public Company)
Kajal Larson, PhD, Senior Director of Clinical Pharmacology and Clinical Development, Innoviva Specialty Therapeutics, leads the development of pipeline assets from early clinical stage to approval, integrating clinical pharmacology principles into efficient trial design and execution.
Kajal has over a decade of experience in drug development, with an interest in infectious diseases and pediatrics. She received a bachelor’s degree in biochemistry from Louisiana State University and her doctoral degree in Pharmacology and Toxicology from the University of Alabama at Birmingham (UAB). Following her post-doctoral training in clinical pharmacology at UAB, she joined industry to pursue drug development and is committed to bringing highly needed therapies to patients and the fight against drug resistance.